The acquisition gives AstraZeneca full global control of the therapy’s development, manufacturing and commercialisation.

AbelZeta Pharma, Inc. ("AbelZeta"), a global clinical-stage biopharmaceutical company focused on the discovery and ...

Wednesday: Mostly sunny and not as cold, with a high of 40 and low of 31 degrees.

AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use ...

AstraZeneca is relying on several upcoming products to help hit its target of $80 billion in revenue by 2030, including drugs ...

AstraZeneca’s $80 billion revenue target for 2030 is “very much within reach,” Chief Fin | While the $80 billion revenue ...

The AstraZeneca share price has risen to all-time highs over the past 12 months. Dr James Fox wishes he had more of the ...

As AstraZeneca floods money into the U.S. market with a wide-ranging investment plan, the company has tapped an in-house ...

Modella AI, a leader in artificial intelligence for life sciences, today announced that it has been acquired by AstraZeneca, ...

Walmart (WMT) stock joins the Nasdaq-100 on Jan. 20, 2026, replacing AstraZeneca (AZN) stock—potentially driving $19B in ...

The company is embracing AI integration throughout drug development, aiming to improve efficiency and drive portfolio ...

Investing.com - Guggenheim has reiterated its Buy rating on AstraZeneca (NASDAQ:AZN) (AZN:LN) with a price target of ...